- |||||||||| KHK4577 / Kyowa Kirin
Enrollment closed: Phase 2 Study of KHK4577 (clinicaltrials.gov) - Jan 9, 2015 P2, N=90, Active, not recruiting, N=100 --> 54 | Recruiting --> Terminated; Patient recruitment is very slow, economic grant has ended and the number of patients is enough according to sample size (22 children/ arm). Recruiting --> Active, not recruiting
- |||||||||| Trial completion, Trial primary completion date: Trial of L-DOPA as a Treatment to Improve Vision in Albinism (clinicaltrials.gov) - Dec 12, 2014
P2, N=47, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Dec 2014
- |||||||||| Enrollment open: Bleach Bath Treatment of Adults With Atopic Dermatitis (clinicaltrials.gov) - Nov 24, 2014
P=N/A, N=40, Recruiting, Recruiting --> Completed | N=20 --> 7 | Trial primary completion date: Mar 2014 --> Oct 2014 Not yet recruiting --> Recruiting
- |||||||||| tacrolimus topical / Generic mfg.
Enrollment open, Trial primary completion date, Adherence: Protopic Adherence and Efficacy in Korean Eczema Patient (clinicaltrials.gov) - Nov 4, 2014 P=N/A, N=50, Recruiting, Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Trial primary completion date: Mar 2015 --> Mar 2016
- |||||||||| lenalidomide / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: LENAKAP: Lenalidomide in Kaposi Disease Associated With HIV Infection (clinicaltrials.gov) - Aug 1, 2014 P2, N=12, Terminated, Recruiting --> Active, not recruiting N=35 --> 12 | Active, not recruiting --> Terminated | Trial primary completion date: Oct 2013 --> Feb 2014
- |||||||||| Stelara (ustekinumab) / J&J
Enrollment closed: A Study of Ustekinumab (STELARA (clinicaltrials.gov) - Jul 27, 2014 P2, N=79, Active, not recruiting, Not yet recruiting --> Recruiting | Phase classification: P1/2 --> P2 Recruiting --> Active, not recruiting
|